MobiHealthNews

Pear's reSET-O DTx lowers costs, enhances quality of life in new study

Over 12 weeks, using reSET-O in addition to treatment as usual lowered costs by $1,014 and added 0.003 quality-adjusted life years compared with normal treatment alone. Treatment as usual was ...
MobiHealthNews

Pear's reSET-O for opioid use disorder saves payers $2,150 per patient, real-world claims review finds

A recently published review of real-world claims data suggests that opioid use disorder patients prescribed Pear Therapeutics' reSET-O digital therapeutic, alongside pharmacotherapy, had fewer ...
BioWorld

Data shows Pear’s Reset-O significantly reduces health care utilization in patients with opioid use disorder

Pear Therapeutics Inc. released nine-month, real-world data showing long-term reduction in costly health care utilization categories, including inpatient stays and emergency department visits, in ...
Business Wire

Pear Therapeutics and Serve You Rx Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® and People with Substance and Opioid Use Disorders

Serve You Rx teams with Pear to lead access to prescription digital therapeutics (PDTs) with proven outcomes in treating substance use disorder (SUD) and opioid use disorder (OUD) and to support ...
Business Wire

Pear Therapeutics Announces Publication of Real-World Data Showing Improved Clinical Outcomes with a Subsequent Prescription of reSET-O® for Patients with Opioid Use Disorder

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Pear Therapeutics, Inc., today announced publication of real-world data evaluating the impact of reSET-O, the first and only FDA-authorized Prescription ...
BioWorld

Data shows Pear’s Reset-O significantly reduces health care utilization in patients with opioid use disorder

Pear Therapeutics Inc. released nine-month, real-world data showing long-term reduction in costly health care utilization categories, including inpatient stays and emergency department visits, in ...